NCT01991145View on ClinicalTrials.gov

Allogeneic UCB Therapy With EPO in Children With CP

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 26, 2013

Primary Completion Date

June 24, 2017

Study Completion Date

June 24, 2017

Conditions
Cerebral Palsy
Interventions
PROCEDURE

Umbilical Cord Blood therapy

HLA (Human Leukocyte Antigen) typing

BIOLOGICAL

Erythropoietin alfa

OTHER

Rehabilitation

Active rehabilitation

PROCEDURE

Placebo UCB

BIOLOGICAL

Placebo EPO

Trial Locations (1)

463-712

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors
All Listed Sponsors
collaborator

Ministry of Health & Welfare, Korea

OTHER_GOV

collaborator

LG Life Sciences

INDUSTRY

collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

collaborator

CHA University

OTHER

lead

MinYoung Kim, MD, PhD

OTHER